Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Intravenously-injected gold nanoparticles (AuNPs) access intracerebral F98 rat gliomas better than AuNPs infused directly into the tumor site by convection enhanced delivery.

Smilowitz HM, Meyers A, Rahman K, Dyment NA, Sasso D, Xue C, Oliver DL, Lichtler A, Deng X, Ridwan SM, Tarmu LJ, Wu Q, Salner AL, Bulsara KR, Slatkin DN, Hainfeld JF.

Int J Nanomedicine. 2018 Jul 4;13:3937-3948. doi: 10.2147/IJN.S154555. eCollection 2018.

2.

Gold nanoparticle hyperthermia reduces radiotherapy dose.

Hainfeld JF, Lin L, Slatkin DN, Avraham Dilmanian F, Vadas TM, Smilowitz HM.

Nanomedicine. 2014 Nov;10(8):1609-17. doi: 10.1016/j.nano.2014.05.006. Epub 2014 Jun 3.

3.

Infrared-transparent gold nanoparticles converted by tumors to infrared absorbers cure tumors in mice by photothermal therapy.

Hainfeld JF, O'Connor MJ, Lin P, Qian L, Slatkin DN, Smilowitz HM.

PLoS One. 2014 Feb 10;9(2):e88414. doi: 10.1371/journal.pone.0088414. eCollection 2014.

4.

Microlocalization of lipophilic porphyrins: non-toxic enhancers of boron neutron-capture therapy.

Smilowitz HM, Slatkin DN, Micca PL, Miura M.

Int J Radiat Biol. 2013 Aug;89(8):611-7. doi: 10.3109/09553002.2013.782446. Epub 2013 Apr 25.

PMID:
23484623
5.

Response of the rat spinal cord to X-ray microbeams.

Laissue JA, Bartzsch S, Blattmann H, Bräuer-Krisch E, Bravin A, Dalléry D, Djonov V, Hanson AL, Hopewell JW, Kaser-Hotz B, Keyriläinen J, Laissue PP, Miura M, Serduc R, Siegbahn AE, Slatkin DN.

Radiother Oncol. 2013 Jan;106(1):106-11. doi: 10.1016/j.radonc.2012.12.007. Epub 2013 Jan 12.

PMID:
23321495
6.

Gold nanoparticle imaging and radiotherapy of brain tumors in mice.

Hainfeld JF, Smilowitz HM, O'Connor MJ, Dilmanian FA, Slatkin DN.

Nanomedicine (Lond). 2013 Oct;8(10):1601-9. doi: 10.2217/nnm.12.165. Epub 2012 Dec 24.

7.

A misprint in a description of microbeam irradiations of rats' heads.

Laissue JA, Blattmann H, Siegbahn EA, Slatkin DN.

Vet Ophthalmol. 2012 May;15(3):210-1. doi: 10.1111/j.1463-5224.2012.01023.x. No abstract available.

PMID:
22524162
8.

[Alban Köhler (1874-1947): Inventor of grid therapy].

Laissue JA, Blattmann H, Slatkin DN.

Z Med Phys. 2012 Jun;22(2):90-9. doi: 10.1016/j.zemedi.2011.07.002. Epub 2011 Sep 8. German. Erratum in: Z Med Phys. 2013 Dec;23(4):332.

PMID:
21862299
9.

Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions.

Hainfeld JF, O'Connor MJ, Dilmanian FA, Slatkin DN, Adams DJ, Smilowitz HM.

Br J Radiol. 2011 Jun;84(1002):526-33. doi: 10.1259/bjr/42612922. Epub 2010 Nov 16.

10.

Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma.

Hainfeld JF, Dilmanian FA, Zhong Z, Slatkin DN, Kalef-Ezra JA, Smilowitz HM.

Phys Med Biol. 2010 Jun 7;55(11):3045-59. doi: 10.1088/0031-9155/55/11/004. Epub 2010 May 12.

PMID:
20463371
11.

Prospects for microbeam radiation therapy of brain tumours in children.

Slatkin DN, Blattmann H, Wagner HP, Glotzer MA, Laissue JA.

Dev Med Child Neurol. 2009 Feb;51(2):163. doi: 10.1111/j.1469-8749.2008.03187.x. Epub 2008 Nov 18. No abstract available.

12.

Radiotherapy enhancement with gold nanoparticles.

Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM.

J Pharm Pharmacol. 2008 Aug;60(8):977-85. doi: 10.1211/jpp.60.8.0005. Review.

PMID:
18644191
13.

Prospects for microbeam radiation therapy of brain tumours in children to reduce neurological sequelae.

Laissue JA, Blattmann H, Wagner HP, Grotzer MA, Slatkin DN.

Dev Med Child Neurol. 2007 Aug;49(8):577-81.

14.

Tetrahedral irradiation protocol for microbeam radiation therapy.

Slatkin DN.

Phys Med Biol. 2006 Sep 7;51(17):N295-7. Epub 2006 Aug 8.

PMID:
16912367
15.

Synergy of gene-mediated immunoprophylaxis and microbeam radiation therapy for advanced intracerebral rat 9L gliosarcomas.

Smilowitz HM, Blattmann H, Bräuer-Krisch E, Bravin A, Di Michiel M, Gebbers JO, Hanson AL, Lyubimova N, Slatkin DN, Stepanek J, Laissue JA.

J Neurooncol. 2006 Jun;78(2):135-43. Epub 2006 Apr 6.

PMID:
16598429
16.

Gold nanoparticles: a new X-ray contrast agent.

Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM.

Br J Radiol. 2006 Mar;79(939):248-53.

PMID:
16498039
17.

Radiosurgical palliation of aggressive murine SCCVII squamous cell carcinomas using synchrotron-generated X-ray microbeams.

Miura M, Blattmann H, Bräuer-Krisch E, Bravin A, Hanson AL, Nawrocky MM, Micca PL, Slatkin DN, Laissue JA.

Br J Radiol. 2006 Jan;79(937):71-5.

PMID:
16421408
18.

The effect of temperature variation in vitro on platelet-leukocyte interactions and individual prothrombotic potential.

Li Y, Becker KC, Slatkin D, Spencer F, Becker RC.

J Thromb Thrombolysis. 2004 Aug;18(1):19-23.

PMID:
15744549
19.

The use of gold nanoparticles to enhance radiotherapy in mice.

Hainfeld JF, Slatkin DN, Smilowitz HM.

Phys Med Biol. 2004 Sep 21;49(18):N309-15.

PMID:
15509078
20.

Uniaxial and biaxial irradiation protocols for microbeam radiation therapy.

Slatkin DN.

Phys Med Biol. 2004 Jul 7;49(13):N203-4.

PMID:
15285266
21.

Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice.

Miura M, Morris GM, Micca PL, Nawrocky MM, Makar MS, Cook SP, Slatkin DN.

Br J Radiol. 2004 Jul;77(919):573-80.

PMID:
15238404
22.

The combination of X-ray-mediated radiosurgery and gene-mediated immunoprophylaxis for advanced intracerebral gliosarcomas in rats.

Smilowitz HM, Coderre JA, Nawrocky MM, Tu W, Pinkerton A, Jahng GH, Gebbers N, Slatkin DN.

J Neurooncol. 2002 Mar;57(1):9-18.

PMID:
12125969
23.

Biodistribution of copper carboranyltetraphenylporphyrins in rodents bearing an isogeneic or human neoplasm.

Miura M, Joel DD, Smilowitz HM, Nawrocky MM, Micca PL, Hoch DA, Coderre JA, Slatkin DN.

J Neurooncol. 2001 Apr;52(2):111-7.

PMID:
11508810
24.

Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin.

Miura M, Morris GM, Micca PL, Lombardo DT, Youngs KM, Kalef-Ezra JA, Hoch DA, Slatkin DN, Ma R, Coderre JA.

Radiat Res. 2001 Apr;155(4):603-10.

PMID:
11260662
25.

Research at the European Synchrotron Radiation Facility medical beamline.

Thomlinson W, Berkvens P, Berruyer G, Bertrand B, Blattmann H, Brauer-Krisch E, Brochard T, Charvet AM, Corde S, Dimichiel M, Elleaume H, Estève F, Fiedler S, Laissue JA, Le Bas JE, Le Duc G, Lyubimova N, Nemoz C, Renier M, Slatkin DN, Spanne P, Suortti P.

Cell Mol Biol (Noisy-le-grand). 2000 Sep;46(6):1053-63. Review.

PMID:
10976863
26.

Physics study of microbeam radiation therapy with PSI-version of Monte Carlo code GEANT as a new computational tool.

Stepanek J, Blattmann H, Laissue JA, Lyubimova N, Di Michiel M, Slatkin DN.

Med Phys. 2000 Jul;27(7):1664-75. Erratum in: Med Phys 2001 Feb;28(2):290.

PMID:
10947271
27.

The combination of boron neutron-capture therapy and immunoprophylaxis for advanced intracerebral gliosarcomas in rats.

Smilowitz HM, Micca PL, Nawrocky MM, Slatkin DN, Tu W, Coderre JA.

J Neurooncol. 2000;46(3):231-40.

PMID:
10902854
28.

Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells.

Smilowitz HM, Joel DD, Slatkin DN, Micca PL, Nawrocky MM, Youngs K, Tu W, Coderre JA.

J Neurooncol. 2000;46(3):193-203.

PMID:
10902851
29.

Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies

Chanana AD, Capala J, Chadha M, Coderre JA, Diaz AZ, Elowitz EH, Iwai J, Joel DD, Liu HB, Ma R, Pendzick N, Peress NS, Shady MS, Slatkin DN, Tyson GW, Wielopolski L.

Neurosurgery. 1999 Jun;44(6):1182-92; discussion 1192-3.

PMID:
10371617
30.

Neuropathology of ablation of rat gliosarcomas and contiguous brain tissues using a microplanar beam of synchrotron-wiggler-generated X rays.

Laissue JA, Geiser G, Spanne PO, Dilmanian FA, Gebbers JO, Geiser M, Wu XY, Makar MS, Micca PL, Nawrocky MM, Joel DD, Slatkin DN.

Int J Cancer. 1998 Nov 23;78(5):654-60.

31.

Innovation at Midwestern.

Slatkin DJ, MacKinnon GE 3rd.

J Am Pharm Assoc (Wash). 1998 Sep-Oct;38(5):516. No abstract available.

PMID:
9782683
32.

Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.

Miura M, Micca PL, Fisher CD, Gordon CR, Heinrichs JC, Slatkin DN.

Br J Radiol. 1998 Jul;71(847):773-81.

PMID:
9771389
33.
34.

Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.

Coderre JA, Chanana AD, Joel DD, Elowitz EH, Micca PL, Nawrocky MM, Chadha M, Gebbers JO, Shady M, Peress NS, Slatkin DN.

Radiat Res. 1998 Feb;149(2):163-70.

PMID:
9457896
35.

Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.

Coderre JA, Elowitz EH, Chadha M, Bergland R, Capala J, Joel DD, Liu HB, Slatkin DN, Chanana AD.

J Neurooncol. 1997 May;33(1-2):141-52.

PMID:
9151231
36.

Single-and dual-energy CT with monochromatic synchrotron x-rays.

Dilmanian FA, Wu XY, Parsons EC, Ren B, Kress J, Button TM, Chapman LD, Coderre JA, Giron F, Greenberg D, Krus DJ, Liang Z, Marcovici S, Petersen MJ, Roque CT, Shleifer M, Slatkin DN, Thomlinson WC, Yamamoto K, Zhong Z.

Phys Med Biol. 1997 Feb;42(2):371-87.

PMID:
9044419
37.

Synthesis of a nickel tetracarboranylphenylporphyrin for boron neutron-capture therapy: biodistribution and toxicity in tumor-bearing mice.

Miura M, Micca PL, Fisher CD, Heinrichs JC, Donaldson JA, Finkel GC, Slatkin DN.

Int J Cancer. 1996 Sep 27;68(1):114-9.

38.

Subacute neuropathological effects of microplanar beams of x-rays from a synchrotron wiggler.

Slatkin DN, Spanne P, Dilmanian FA, Gebbers JO, Laissue JA.

Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8783-7.

39.

Glioblastoma treatment.

Slatkin DN.

Science. 1994 Sep 16;265(5179):1644. No abstract available.

PMID:
7993457
40.

Improved apparatus for neutron capture therapy of rat brain tumors.

Liu HB, Joel DD, Slatkin DN, Coderre JA.

Int J Radiat Oncol Biol Phys. 1994 Mar 30;28(5):1167-73.

PMID:
8175402
41.

Derivations of relative biological effectiveness for the high-let radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo.

Coderre JA, Makar MS, Micca PL, Nawrocky MM, Liu HB, Joel DD, Slatkin DN, Amols HI.

Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1121-9.

PMID:
8262837
42.

A commentary on in vivo lead X-ray fluorescence with reference to the 1992 workshop.

Rosen JF, Slatkin DN.

Neurotoxicology. 1993 Winter;14(4):537-40.

PMID:
8164895
43.

Microbeam radiation therapy.

Slatkin DN, Spanne P, Dilmanian FA, Sandborg M.

Med Phys. 1992 Nov-Dec;19(6):1395-400.

PMID:
1461201
44.

Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine.

Coderre JA, Joel DD, Micca PL, Nawrocky MM, Slatkin DN.

Radiat Res. 1992 Mar;129(3):290-6.

PMID:
1542717
45.

Alkaloids of Thalictrum glandulosissimum.

Lou ZC, Gao CY, Lin FT, Zhang J, Lin MC, Sharaf M, Wong LK, Slatkin DJ, Schiff PL Jr.

Planta Med. 1992 Feb;58(1):114. No abstract available.

PMID:
1620736
46.

Biodistribution and toxicity of 2,4-divinyl-nido-o-carboranyldeuteroporphyrin IX in mice.

Miura M, Micca PL, Heinrichs JC, Gabel D, Fairchild RG, Slatkin DN.

Biochem Pharmacol. 1992 Feb 4;43(3):467-76. Erratum in: Biochem Pharmacol 1995 Sep 7;50(6):893-4.

PMID:
1540204
47.

Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index.

Coderre JA, Slatkin DN, Micca PL, Ciallella JR.

Radiat Res. 1991 Nov;128(2):177-85.

PMID:
1947013
49.

Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.

Rosen JF, Markowitz ME, Bijur PE, Jenks ST, Wielopolski L, Kalef-Ezra JA, Slatkin DN.

Environ Health Perspect. 1991 Jun;93:271-7.

50.

Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children.

Rosen JF, Markowitz ME, Bijur PE, Jenks ST, Wielopolski L, Kalef-Ezra JA, Slatkin DN.

Environ Health Perspect. 1991 Feb;91:57-62. Erratum in: Environ Health Perspect 1991 May;92:181.

Supplemental Content

Loading ...
Support Center